ThermoFisher’s most recent trend suggests a bullish bias. One trading opportunity on ThermoFisher is a Bull Put Spread using a strike $550.00 short put and a strike $530.00 long put offers a potential 11.42% return on risk over the next 10 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $550.00 by expiration. The full premium credit of $2.05 would be kept by the premium seller. The risk of $17.95 would be incurred if the stock dropped below the $530.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for ThermoFisher is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for ThermoFisher is bullish.
The RSI indicator is at 59.84 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for ThermoFisher
Thermo Fisher (TMO) Gains Government Contract for Pipette Tip
Fri, 03 Sep 2021 13:09:01 +0000
Thermo Fisher (TMO) will co-invest with the U.S. government to build a new manufacturing center for pipette tips in North Carolina.
Thermo Fisher Receives $192.5M Contract From US Govt For Pipette Tip Manufacturing
Thu, 02 Sep 2021 17:14:05 +0000
Thermo Fisher Scientific Inc (NYSE: TMO) has announced a $192.5 million contract award from the U.S. Department of Defense (DoD). The contract covers the domestic production of pipette tips used within research and diagnostic labs to dispense precise amounts of liquid. In mid-2020, the company announced its investments to increase pipette tip production capacity to support COVID-19 testing. With the DoD award, issued on behalf of and in coordination with the U.S. Department of Health and Human S
REFILE-Thermo Fisher gets $192.5 mln U.S. contract to boost lab device production
Thu, 02 Sep 2021 13:10:35 +0000
Thermo Fisher Scientific Inc won a $192.5 million award from the U.S. Department of Defense to expand production of a device used in diagnostic tests including those for COVID-19, the biggest U.S. maker of scientific instruments said. The United States is facing a shortage of COVID-19 tests as schools and employers revive surveillance programs following a resurgence in cases due to the highly contagious Delta variant.
Thermo Fisher Scientific Awarded $192.5 Million U.S. Government Contract to Expand Domestic Pipette Tip Manufacturing
Thu, 02 Sep 2021 12:00:00 +0000
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a $192.5 million contract award from the U.S. Department of Defense (DoD) to ensure reliable domestic production of pipette tips, which are used within research and diagnostic labs to dispense precise amounts of liquid. In mid-2020, the company announced its own investments to increase pipette tip production capacity to support COVID-19 testing.
Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know
Wed, 01 Sep 2021 21:50:09 +0000
Thermo Fisher Scientific (TMO) closed the most recent trading day at $561.72, moving +1.22% from the previous trading session.
Follow Us on Facebook